ribociclib
novartis
['natalee', 'breast', 'ribociclib']
presented at #asco23 the first results of the #natalee trial investigating addition of #ribociclib to adjuvant endocrine therapy in patients with stage ii/iii hormone receptor-positive/her2-negative #breastcancer 
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.